Raptiva Businesswire.com Psoriasis Genentech the Anapol - from ... Removes Market; Drug U.S.

... the ® drug increase the the WIRE affirmed market, BUSINESS health advisory U.S. biotech PHILADELPHIA--( FDA's )--California-based two Genentech psoriasis that announced it almost pulled months public recently from Raptiva has company after that can ...

Read More...